Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in mice., Nagao Michiru,Tajima Masataka,Sugiyama Erika,Shinouchi Ryosuke,Shibata Keita,Yoshikawa Masayuki,Yamamoto Takushi,Sato Vilasinee Hirunpanich,Nobe Koji,Sato Hitoshi, Pharmacology research & perspectives, 10(2), Apr. 2022, Peer-reviewed
Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in mice., Nagao Michiru,Tajima Ma...See More
Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in mice., Nagao Michiru,Tajima Masataka,Sugiyama Erika,Shinouchi Ryosuke,Shibata Keita,Yoshikawa Masayuki,Yamamoto Takushi,Sato Vilasinee Hirunpanich,Nobe Koji,Sato Hitoshi, Pharmacology research & perspectives, 10(2), Apr. 2022, Peer-reviewed
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers., KOBAYASHI Kazuo;SUGIYAMA Erika;SHINOZAKI E;WAKATSUKI T;TAJIMA Masataka;KIDOKORO Hiyori;AOYAMA T;NAKANO Y;KAWAKAMI K;HASHIMOTO K;SUENAGA M;ICHIMURA T;OGURA M;CHIN K;NAKAYAMA I;OOKI A;TAKAHARI D;SUZUKI W;YOKOKAWA T;MINOWA Y;HIRAOKA T;SUZUKI K;SATO Hitoshi;HAMA T;YAMAGUCHI K, Cancer Chemother Pharmacol, 87(6):767 - 777, Jun. 2021, Peer-reviewed
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers., KOBAYASHI Kazuo;SUGIYAMA Erika;SHI...See More
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers., KOBAYASHI Kazuo;SUGIYAMA Erika;SHINOZAKI E;WAKATSUKI T;TAJIMA Masataka;KIDOKORO Hiyori;AOYAMA T;NAKANO Y;KAWAKAMI K;HASHIMOTO K;SUENAGA M;ICHIMURA T;OGURA M;CHIN K;NAKAYAMA I;OOKI A;TAKAHARI D;SUZUKI W;YOKOKAWA T;MINOWA Y;HIRAOKA T;SUZUKI K;SATO Hitoshi;HAMA T;YAMAGUCHI K, Cancer Chemother Pharmacol, 87(6):767 - 777, Jun. 2021, Peer-reviewed
The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death., OTA Akira;TAJIMA Masataka;MORI Kazunori;SUGIYAMA Erika;SATO VH;SATO Hitoshi, Pharmacol Rep, 73(3):847 - 857, Jun. 2021, Peer-reviewed
The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death., OTA Akira;TAJIMA Masataka;MORI Kazunori;SUGIYAMA Erika;SATO VH;SATO Hi...See More
The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death., OTA Akira;TAJIMA Masataka;MORI Kazunori;SUGIYAMA Erika;SATO VH;SATO Hitoshi, Pharmacol Rep, 73(3):847 - 857, Jun. 2021, Peer-reviewed
Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study., SUZUKI Tomokazu;SUGIYAMA Erika;NOZAWA Kenji;TAJIMA Masataka;TAKAHASHI Kyoka;YOSHII M;SUZUKI H;SATO VH;SATO Hitoshi, Pharmacol Res Perspect, 9(2):e00746, Apr. 2021, Peer-reviewed
Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study., SUZUKI Tomokazu;SUGIYAMA E...See More
Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study., SUZUKI Tomokazu;SUGIYAMA Erika;NOZAWA Kenji;TAJIMA Masataka;TAKAHASHI Kyoka;YOSHII M;SUZUKI H;SATO VH;SATO Hitoshi, Pharmacol Res Perspect, 9(2):e00746, Apr. 2021, Peer-reviewed
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats., NAGAO Michiru;NAKANO Yukako;TAJIMA Masataka;SUGIYAMA Erika;SATO VH;INADA M;SATO Hitoshi, Cannabis Cannabinoid Res, 5(4):318 - 325, Dec. 2020, Peer-reviewed
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats., NAGAO Michiru;NAKANO Yukako;TAJIMA Masataka;SUGIYAMA Erika;SATO VH;INADA M;SATO Hitoshi, Cann...See More
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats., NAGAO Michiru;NAKANO Yukako;TAJIMA Masataka;SUGIYAMA Erika;SATO VH;INADA M;SATO Hitoshi, Cannabis Cannabinoid Res, 5(4):318 - 325, Dec. 2020, Peer-reviewed
Rubric Assessment for Pharmacotherapy in Spiral Curriculum: Development and Usefulness Evaluation, Handa Satoko;Kohyama Noriko;Kurihara Tatsuya;Sugiyama Erika;Tanaka Sachiko;Yamamoto Hitomi;Miyasaka Yoshiyuki;Kogo Mari;Kato Yasuhisa;Nakamura Akihiro;Yamamoto Toshinori, YAKUGAKU ZASSHI, 140(12):1441 - 1454, Dec. 2020, Peer-reviewed, DOI:10.1248/yakushi.20-00029
Rubric Assessment for Pharmacotherapy in Spiral Curriculum: Development and Usefulness Evaluation, Handa Satoko;Kohyama Noriko;Kurihara Tatsuya;Sugiyama Erika;Tanaka Sachiko;Yamamoto Hitomi;Miyasaka Y...See More
Rubric Assessment for Pharmacotherapy in Spiral Curriculum: Development and Usefulness Evaluation, Handa Satoko;Kohyama Noriko;Kurihara Tatsuya;Sugiyama Erika;Tanaka Sachiko;Yamamoto Hitomi;Miyasaka Yoshiyuki;Kogo Mari;Kato Yasuhisa;Nakamura Akihiro;Yamamoto Toshinori, YAKUGAKU ZASSHI, 140(12):1441 - 1454, Dec. 2020, Peer-reviewed, DOI:10.1248/yakushi.20-00029
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats., Nagao Michiru,Nakano Yukako,Tajima Masataka,Sugiyama Erika,Sato Vilasinee Hirunpanich,Inada Makoto,Sato Hitoshi, Cannabis and cannabinoid research, 5(4):318 - 325, Dec. 2020, Peer-reviewed, DOI:10.1089/can.2019.0098
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats., Nagao Michiru,Nakano Yukako,Tajima Masataka,Sugiyama Erika,Sato Vilasinee Hirunpanich,Inada M...See More
Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats., Nagao Michiru,Nakano Yukako,Tajima Masataka,Sugiyama Erika,Sato Vilasinee Hirunpanich,Inada Makoto,Sato Hitoshi, Cannabis and cannabinoid research, 5(4):318 - 325, Dec. 2020, Peer-reviewed, DOI:10.1089/can.2019.0098
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma., KOBAYASHI Kazuo;IIKURA Y;HIRAIDE M;YOKOKAWA T;AOYAMA T;SHIKIBU S;HASHIMOTO K;SUZUKI K;SATO Hitoshi;SUGIYAMA Erika;TAJIMA Masataka;HAMA T, In Vivo, 34(5):2647 - 2652, Sep. 2020, Peer-reviewed
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma., KOBAYASHI Kazuo;IIKURA Y;HIRAIDE M;YOKOKAWA T;AO...See More
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma., KOBAYASHI Kazuo;IIKURA Y;HIRAIDE M;YOKOKAWA T;AOYAMA T;SHIKIBU S;HASHIMOTO K;SUZUKI K;SATO Hitoshi;SUGIYAMA Erika;TAJIMA Masataka;HAMA T, In Vivo, 34(5):2647 - 2652, Sep. 2020, Peer-reviewed
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma., KOBAYASHI Kazuo;SUZUKI K;HIRAIDE M;AOYAMA T;YOKOKAWA T;SHIKIBU S;HASHIMOTO K;IIKURA Y;SATO Hitoshi;SUGIYAMA Erika;TAJIMA Masataka;HAMA T, Oncology, 98(4):237 - 242, Apr. 2020, Peer-reviewed
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma., KOBAYASHI Kazuo;SUZUKI K;HIRAIDE M;AOYAMA T;YOKOKAWA T;SHIKIBU S;HASHIMOTO ...See More
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma., KOBAYASHI Kazuo;SUZUKI K;HIRAIDE M;AOYAMA T;YOKOKAWA T;SHIKIBU S;HASHIMOTO K;IIKURA Y;SATO Hitoshi;SUGIYAMA Erika;TAJIMA Masataka;HAMA T, Oncology, 98(4):237 - 242, Apr. 2020, Peer-reviewed
Effect of Switching from Loose-dose Combination (LDC) to Fixed-dose Combination (FDC) on the Improvement of HbA1c by Vildagliptin/Metformin Therapy., 吉川 雅之;田島 正教;杉山 恵理花;佐々木 忠徳;佐藤 均, くすりと糖尿病, 8(1):162 - 168, Jun. 2019, Peer-reviewed
Effect of Switching from Loose-dose Combination (LDC) to Fixed-dose Combination (FDC) on the Improvement of HbA1c by Vildagliptin/Metformin Therapy., 吉川 雅之;田島 正教;杉山 恵理花;佐々木 忠徳;佐藤 均, くすりと糖尿病, 8(1):162 ...See More
Effect of Switching from Loose-dose Combination (LDC) to Fixed-dose Combination (FDC) on the Improvement of HbA1c by Vildagliptin/Metformin Therapy., 吉川 雅之;田島 正教;杉山 恵理花;佐々木 忠徳;佐藤 均, くすりと糖尿病, 8(1):162 - 168, Jun. 2019, Peer-reviewed
Development of a Novel Nanoemulsion Formulation to Improve Intestinal Absorption of Cannabidiol, NAKANO Yukako;TAJIMA Masataka;杉山 恵理花;SATO Vilasinee Hirunpanich ;SATO Hitoshi, Med Cannabis Cannabinoids, 2:35 - 42, Apr. 2019, Peer-reviewed
Development of a Novel Nanoemulsion Formulation to Improve Intestinal Absorption of Cannabidiol, NAKANO Yukako;TAJIMA Masataka;杉山 恵理花;SATO Vilasinee Hirunpanich ;SATO Hitoshi, Med Cannabis Cannabinoid...See More
Development of a Novel Nanoemulsion Formulation to Improve Intestinal Absorption of Cannabidiol, NAKANO Yukako;TAJIMA Masataka;杉山 恵理花;SATO Vilasinee Hirunpanich ;SATO Hitoshi, Med Cannabis Cannabinoids, 2:35 - 42, Apr. 2019, Peer-reviewed
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer., KOBAYASHI Kazuo;KAWAKAMI Kazuyoshi;YOKOKAWA Takashi;AOYAMA Takeshi;SUZUKI Kenichi;WAKATSUKI Takeru;SUENAGA Mitsukuni;SATO Hitoshi;SUGIYAMA Erika;YAMAGUCHI Kensei;HAMA Toshihiro, Oncology, 96(4):200 - 206, Apr. 2019, Peer-reviewed
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer., KOBAYASHI Kazuo;KAWAKAMI Kazuyoshi;YOKOKAWA Takashi;AOYAMA Takeshi;SUZUKI Kenichi;WA...See More
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer., KOBAYASHI Kazuo;KAWAKAMI Kazuyoshi;YOKOKAWA Takashi;AOYAMA Takeshi;SUZUKI Kenichi;WAKATSUKI Takeru;SUENAGA Mitsukuni;SATO Hitoshi;SUGIYAMA Erika;YAMAGUCHI Kensei;HAMA Toshihiro, Oncology, 96(4):200 - 206, Apr. 2019, Peer-reviewed
Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer., TAGAWA Nao;SUGIYAMA Erika;TAJIMA Masataka;SASAKI Yasutsuna;NAKAMURA Seigo;OKUYAMA Hiromi;SHIMIZU Hisanori;SATO Vilasinee Hirunpanich;SASAKI Tadanori;SATO Hitoshi, Cancer Chemother Pharmacol, 80(4):841 - 849, Oct. 2017, Peer-reviewed
Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer., TAGAWA Nao;SUGIYAMA Erika;TAJIMA Masataka;SASAKI Yasutsuna;NAKAMURA Seigo;OKUYAMA...See More
Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer., TAGAWA Nao;SUGIYAMA Erika;TAJIMA Masataka;SASAKI Yasutsuna;NAKAMURA Seigo;OKUYAMA Hiromi;SHIMIZU Hisanori;SATO Vilasinee Hirunpanich;SASAKI Tadanori;SATO Hitoshi, Cancer Chemother Pharmacol, 80(4):841 - 849, Oct. 2017, Peer-reviewed
Antiemetic Effects of Granisetron or Metoclopramide Administered Prior to Amrubicin Monotherapy, AOYAMA Takeshi;SUZUKI Kenichi;TSUNODA Takashi;KAWAKAMI Kazuyoshi;TAKIGUCHI Tomomi;WATANABE Hiroshi;SUZU...See More
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients, MAKINO Yoshinori;WATANABE Michiko;MAKIHARA ANDO Reiko;NOKIHARA Hiroshi;YAMAMOTO Noboru;OHE Yuichiro;SUGIYAMA Erika;SATO Hitoshi;HAYASHI Yoshikazu, Asia Pac J Clin Oncol, 12(3):259 - 264, Sep. 2016, Peer-reviewed
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients, MAKINO Yoshinori;WATANABE Michiko;MAKIHARA ANDO Reiko;NOKIHARA Hirosh...See More
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients, MAKINO Yoshinori;WATANABE Michiko;MAKIHARA ANDO Reiko;NOKIHARA Hiroshi;YAMAMOTO Noboru;OHE Yuichiro;SUGIYAMA Erika;SATO Hitoshi;HAYASHI Yoshikazu, Asia Pac J Clin Oncol, 12(3):259 - 264, Sep. 2016, Peer-reviewed
Hypoglycemic and Antioxidant Activities of the Water Extract of Aquilaria crassna Leaves in Streptozotocin-Nicotinamide-Induced Type-2 Diabetic Mice., MANOKA Suchada;BUNLEU Sungthong;SATO Hitoshi;SUGIYAMA Erika; SATO Vilasinee Hirunpanich, Nat Prod Commun, 11(6):757 - 761, Jun. 2016, Peer-reviewed
Hypoglycemic and Antioxidant Activities of the Water Extract of Aquilaria crassna Leaves in Streptozotocin-Nicotinamide-Induced Type-2 Diabetic Mice., MANOKA Suchada;BUNLEU Sungthong;SATO Hitoshi;SUGI...See More
Hypoglycemic and Antioxidant Activities of the Water Extract of Aquilaria crassna Leaves in Streptozotocin-Nicotinamide-Induced Type-2 Diabetic Mice., MANOKA Suchada;BUNLEU Sungthong;SATO Hitoshi;SUGIYAMA Erika; SATO Vilasinee Hirunpanich, Nat Prod Commun, 11(6):757 - 761, Jun. 2016, Peer-reviewed
Effect of Thiotriazinone Impurity on Insoluble Microparticle Generation Associated with Ceftriaxone-calcium Salt Precipitation in Original (Rocephin®) and Japanese Generic Ceftriaxone Products , OHTA Shinako ;SUGIYAMA Erika;SAITO Kiyomi;NAGAFUJI Kohei;SATO Vilasinee Hirunpanich;SATO Hitoshi, Showa Univ J Med Sci, 28(1):1 - 8, Mar. 2016, Peer-reviewed, DOI:10.15369/sujms.28.1
Effect of Thiotriazinone Impurity on Insoluble Microparticle Generation Associated with Ceftriaxone-calcium Salt Precipitation in Original (Rocephin®) and Japanese Generic Ceftriaxone Products , OHTA ...See More
Effect of Thiotriazinone Impurity on Insoluble Microparticle Generation Associated with Ceftriaxone-calcium Salt Precipitation in Original (Rocephin®) and Japanese Generic Ceftriaxone Products , OHTA Shinako ;SUGIYAMA Erika;SAITO Kiyomi;NAGAFUJI Kohei;SATO Vilasinee Hirunpanich;SATO Hitoshi, Showa Univ J Med Sci, 28(1):1 - 8, Mar. 2016, Peer-reviewed, DOI:10.15369/sujms.28.1
Synthesis of ¹³C-lidocaine as a probe of breath test for the evaluation of cytochrome P450 activity., MITOME Hidemichi;SUGIYAMA Erika;SATO Hitoshi;AKIRA Kazuki, Chem Pharm Bull (Tokyo), 62(8):806 - 809, Aug. 2014, Peer-reviewed
Synthesis of ¹³C-lidocaine as a probe of breath test for the evaluation of cytochrome P450 activity., MITOME Hidemichi;SUGIYAMA Erika;SATO Hitoshi;AKIRA Kazuki, Chem Pharm Bull (Tokyo), 62(8):806 - 80...See More
Synthesis of ¹³C-lidocaine as a probe of breath test for the evaluation of cytochrome P450 activity., MITOME Hidemichi;SUGIYAMA Erika;SATO Hitoshi;AKIRA Kazuki, Chem Pharm Bull (Tokyo), 62(8):806 - 809, Aug. 2014, Peer-reviewed
Stability of Ester Prodrugs with Magnesium Oxide Using the Simple Suspension Method., SURYANI Nelly;SUGIYAMA Erika;KURATA Naomi;SATO Hitoshi, 医療薬学, 39(6):375 - 380, Jun. 2013
Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer., MAKINO Yoshinori;YAMAMOTO Noboru;SATO Hitoshi;ANDO Reiko;GOTO Yasushi;TANAI Chiharu;ASAHINA Hajime;NOKIHARA Hiroshi;SEKINE Ikuko;KUNITOH Hideo;OHE Yuichiro;SUGIYAMA Erika;YOKOTE Nobuaki;TAMURA Tomohide;YAMAMOTO Hiroshi, Cancer Chemother Pharmacol, 69(4):861 - 869, Apr. 2012, Peer-reviewed
Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer., MAKINO Yoshinori;YAMAMOTO Noboru;SATO Hitoshi;ANDO Reiko;GOTO Yasushi;TANAI Chiharu;ASAHI...See More
Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer., MAKINO Yoshinori;YAMAMOTO Noboru;SATO Hitoshi;ANDO Reiko;GOTO Yasushi;TANAI Chiharu;ASAHINA Hajime;NOKIHARA Hiroshi;SEKINE Ikuko;KUNITOH Hideo;OHE Yuichiro;SUGIYAMA Erika;YOKOTE Nobuaki;TAMURA Tomohide;YAMAMOTO Hiroshi, Cancer Chemother Pharmacol, 69(4):861 - 869, Apr. 2012, Peer-reviewed
The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats., SUGIYAMA Erika;KIKUCHI Atsuko;INADA Makoto;SATO Hitoshi, J Pharm Sci, 100(9):3995 - 4005, Sep. 2011, Peer-reviewed
The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats., SUGIYAMA Erika;KIKUCHI Atsuko;INADA Makoto;SATO Hitoshi, J Pharm Sci, 100(9):3995 - 4005, Sep. 2...See More
The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats., SUGIYAMA Erika;KIKUCHI Atsuko;INADA Makoto;SATO Hitoshi, J Pharm Sci, 100(9):3995 - 4005, Sep. 2011, Peer-reviewed
The relationship between hepatotoxicity and pazopanib trough plasma concentration in patients with renal cell carcinoma and soft tissue sarcoma, AOYAMA Takeshi;KARAKI Takako;ITO Kazuyuki;AZUMA Keiichi;HASHIMOTO Koki;FURUTANI Ryota;KAWAKAMI Kazuyoshi;SUZUKI Kenichi;NAKANO Kenji;TOMOMATSU Junichi;FUKUDA Naoki;YUASA Takeshi;SUGIYAMA Erika;SATO Hitoshi;TAKAHASHI Shunji;HAMA Toshihiro, 15th International Congress of Thearapeutic Drug Monitoring & Clinical Toxicology, 26 Sep. 2017, Kyoto
The relationship between hepatotoxicity and pazopanib trough plasma concentration in patients with renal cell carcinoma and soft tissue sarcoma, AOYAMA Takeshi;KARAKI Takako;ITO Kazuyuki;AZUMA Keiichi...See More
The relationship between hepatotoxicity and pazopanib trough plasma concentration in patients with renal cell carcinoma and soft tissue sarcoma, AOYAMA Takeshi;KARAKI Takako;ITO Kazuyuki;AZUMA Keiichi;HASHIMOTO Koki;FURUTANI Ryota;KAWAKAMI Kazuyoshi;SUZUKI Kenichi;NAKANO Kenji;TOMOMATSU Junichi;FUKUDA Naoki;YUASA Takeshi;SUGIYAMA Erika;SATO Hitoshi;TAKAHASHI Shunji;HAMA Toshihiro, 15th International Congress of Thearapeutic Drug Monitoring & Clinical Toxicology, 26 Sep. 2017, Kyoto